Sabby Management’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
+179,785
| New | +$210K | 0.38% | 17 |
|
|
2024
Q2 | – | Sell |
-48,491
| Closed | -$90.4K | – | 28 |
|
|
2024
Q1 | $90.4K | Sell |
48,491
-115,535
| -70% | -$215K | 0.05% | 27 |
|
|
2023
Q4 | $512K | Sell |
164,026
-14,065
| -8% | -$43.9K | 0.51% | 6 |
|
|
2023
Q3 | $703K | Sell |
178,091
-191,516
| -52% | -$756K | 0.51% | 7 |
|
|
2023
Q2 | $1.26M | Sell |
369,607
-27,486
| -7% | -$93.5K | 1.03% | 4 |
|
|
2023
Q1 | $1.44M | Buy |
397,093
+213,676
| +116% | +$776K | 1.26% | 2 |
|
|
2022
Q4 | $1.72M | Sell |
183,417
-21,738
| -11% | -$204K | 1.51% | 6 |
|
|
2022
Q3 | $2.59M | Buy |
+205,155
| New | +$2.59M | 3.26% | 5 |
|
|
2017
Q1 | – | Sell |
-871
| Closed | -$120K | – | 128 |
|
|
2016
Q4 | $120K | Hold |
871
| – | – | 0.01% | 133 |
|
|
2016
Q3 | $148K | Hold |
871
| – | – | 0.01% | 131 |
|
|
2016
Q2 | $235K | Sell |
871
-1,164
| -57% | -$314K | 0.01% | 128 |
|
|
2016
Q1 | $606K | Buy |
+2,035
| New | +$606K | 0.03% | 116 |
|
|
2015
Q1 | – | Sell |
-2,694
| Closed | -$2.59K | – | 127 |
|
|
2014
Q4 | $2.59K | Sell |
2,694
-1,608
| -37% | -$1.54K | 0.08% | 37 |
|
|
2014
Q3 | $5.06K | Buy |
4,302
+202
| +5% | +$238 | 0.19% | 14 |
|
|
2014
Q2 | $4.51M | Buy |
4,100
+755
| +23% | +$831K | 0.19% | 16 |
|
|
2014
Q1 | $4.34M | Buy |
+3,345
| New | +$4.34M | 0.24% | 15 |
|